Comparison of peritoneal function within the first 1 year of peritoneal dialysis between diabetic and non-diabetic patients.

Published on Jun 1, 2021in Therapeutic Apheresis and Dialysis1.041
· DOI :10.1111/1744-9987.13577
Kana Asari1
Estimated H-index: 1
(Jikei University School of Medicine),
Yukio Maruyama18
Estimated H-index: 18
(Jikei University School of Medicine)
+ 7 AuthorsTakashi Yokoo28
Estimated H-index: 28
(Jikei University School of Medicine)
The aim of this study was to compare the changes in peritoneal function and residual renal function in the first year between diabetic and non-diabetic patients receiving peritoneal dialysis (PD). We extracted 73 incident PD patients (male, 73%; age, 59 ± 15 years) from a previous cohort, and investigated the changes in PD-related parameters, including the dialysate to plasma ratio of creatinine (D/P Cr) and Kt/V. D/P Cr increased in non-diabetics, whereas it did not change significantly in diabetic patients. These differences were more pronounced among icodextrin users. On multivariate analysis, the presence of diabetes was independently associated with the changes in D/P Cr. On the contrary, there was no significant difference in the changes of renal Kt/V between the two groups. A higher peritoneal solute transport rate at the start of PD in diabetics was attenuated within 1 year. Icodextrin is thought to have an important role through improving body fluid status.
#1Dharshan Rangaswamy (Manipal University)H-Index: 3
#2Vasudeva Guddattu (Manipal University)H-Index: 12
Last. Kamal Sud (USYD: University of Sydney)H-Index: 25
view all 9 authors...
BACKGROUND: Icodextrin is a high molecular weight, starch-derived glucose polymer that is used as an osmotic agent in peritoneal dialysis (PD) to promote ultrafiltration. There has been wide variation in its use across Australia and the rest of the world, but it is unclear whether these differences are due to patient- or centre-related factors. METHODS: Using the Australia and New Zealand Dialysis and Transplant Registry, all adult patients (>18 years) who started PD in Australia between 1 Janua...
2 CitationsSource
#1Risa Ueda (Jikei University School of Medicine)H-Index: 1
#2Masatsugu Nakao (Jikei University School of Medicine)H-Index: 6
Last. Takashi Yokoo (Jikei University School of Medicine)H-Index: 28
view all 12 authors...
Background Several reports on patients with diabetes mellitus (DM) treated by peritoneal dialysis (PD) have shown a higher risk of PD-associated peritonitis compared to non-DM (NDM) patients. The aim of this study was to investigate the incidence of PD-associated peritonitis in DM patients. Methods We divided all patients who received PD at a single center between January 1980 and December 2012 into three groups according to era: Period 1 (n = 43, 1980–1993); Period 2 (n = 123, 1994–2004); and P...
2 CitationsSource
#1Wim Van Biesen (Ghent University Hospital)H-Index: 70
#2Christian VergerH-Index: 27
Last. Claudio RoncoH-Index: 118
view all 13 authors...
Background and objectives Volume overload is frequent in prevalent patients on kidney replacement therapies and is associated with outcome. This study was devised to follow-up volume status of an incident population on peritoneal dialysis (PD) and to relate this to patient-relevant outcomes. Design, setting, participants, & measurements This prospective cohort study was implemented in 135 study centers from 28 countries. Incident participants on PD were enrolled just before the actual PD treatme...
18 CitationsSource
#1Kyoko Kishida (Jikei University School of Medicine)H-Index: 1
#2Yukio Maruyama (Jikei University School of Medicine)H-Index: 18
Last. Takashi Yokoo (Jikei University School of Medicine)H-Index: 28
view all 10 authors...
Background Although peritoneal dialysis (PD) is becoming more widespread, PD among diabetic patients carries some concerns, such as worsened glycemic control due to constant exposure to glucose and operational errors due to diabetic complications. However, several technical advances could overcome these disadvantages. We, therefore, aimed to compare technical and patient survival between diabetic and non-diabetic PD patients.
4 CitationsSource
#1Hsiao-Ling Chen (Taipei Veterans General Hospital)H-Index: 1
#2Der-Cherng Tarng (Taipei Veterans General Hospital)H-Index: 1
Last. Lian-Hua Huang (NTU: National Taiwan University)H-Index: 15
view all 3 authors...
Peritoneal dialysis (PD) is one option for renal replacement therapy in patients with end-stage renal disease (ESRD). Maintenance of the PD catheter is an important issue for patient outcomes and quality of life. The aim of this retrospective cohort study is to clarify the risk factors of technique failure and outcomes at a single institute in Taiwan. The study enrolled ESRD patients who had received PD catheters in a tertiary hospital in northern Taiwan. Using a competing risks regression model...
9 CitationsSource
#1Rajiv SaranH-Index: 61
#2Bruce M. RobinsonH-Index: 38
Last. Vahakn ShahinianH-Index: 15
view all 69 authors...
Author(s): Saran, Rajiv; Robinson, Bruce; Abbott, Kevin C; Agodoa, Lawrence YC; Bhave, Nicole; Bragg-Gresham, Jennifer; Balkrishnan, Rajesh; Dietrich, Xue; Eckard, Ashley; Eggers, Paul W; Gaipov, Abduzhappar; Gillen, Daniel; Gipson, Debbie; Hailpern, Susan M; Hall, Yoshio N; Han, Yun; He, Kevin; Herman, William; Heung, Michael; Hirth, Richard A; Hutton, David; Jacobsen, Steven J; Jin, Yan; Kalantar-Zadeh, Kamyar; Kapke, Alissa; Kovesdy, Csaba P; Lavallee, Danielle; Leslie, Janet; McCullough, Kei...
399 CitationsSource
#1Anneke Kramer (PHRI: Public Health Research Institute)
#2Maria Pippias (PHRI: Public Health Research Institute)H-Index: 9
Last. Palma BeltránH-Index: 2
view all 41 authors...
This article summarizes the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry's 2015 Annual Report. It describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2015 within 36 countries. In 2016 and 2017, the ERA-EDTA Registry received data on patients who were undergoing RRT for ESRD in 2015, from 52 national or regional renal registries. Thirty-two registries provided individual patient-level data and 20 prov...
169 CitationsSource
Background: Volume overload is frequent in diabetics undergoing peritoneal dialysis (PD), and may play a significant role in the excess mortality observed in thes
4 CitationsSource
#1Aniema Isaac Assam Udo (UNIUYO: University of Uyo)H-Index: 3
#2Catriona GoodladH-Index: 2
Last. Andrew DavenportH-Index: 79
view all 3 authors...
Background: Recent reports have highlighted that diabetic patients with kidney failure are at increased risk of technique failure and transfer to haemodialysis within 90 days of initiating peritoneal dialysis (PD). We wished to determine whether there were differences between diabetic and non-diabetic patients within the first 3 months of starting PD. Methods: We reviewed results of corresponding bioimpedance and the 1st test of peritoneal membrane function (PET) in consecutive patients, 6-10 we...
12 CitationsSource
#1Se Hee Park (Yonsei University)H-Index: 7
#2Joo Young Nam (Dongguk University)H-Index: 8
Last. Eun Seok Kang (Yonsei University)H-Index: 52
view all 9 authors...
Hyperglycemia is associated with increased mortality and morbidity in patients with type 2 diabetes mellitus (T2DM) who are undergoing dialysis. Although dipeptidyl peptidase-4 (DPP-4) inhibitors have been widely used in end-stage renal disease (ESRD) patients with T2DM, there are few studies on their efficacy in this population. We studied the effect of 3 different DPP-4 inhibitors on metabolic parameters in ESRD patients with T2DM. Two hundred ESRD patients with T2DM who were treated with DPP-...
11 CitationsSource
Cited By0